Denmark's Novo Nordisk invests €2.1 billion in France

  • 6 months ago
Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug.

Recommended